[ad_1] Despite those changes and the potential Schedule III classification, some researchers say the study of cannabis may still face limits. “What we haven’t seen is any ability for researchers — cannabis researchers, clinical researchers — to … study products that our patients and our recreational consumers or adult consumers are actually using,” neuroscientist Staci